The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
Lioubov G. Korotchkina(Roswell Park Comprehensive Cancer Center), Mikhail V. Blagosklonny(Roswell Park Comprehensive Cancer Center)
Cited by 274
Related Papers
Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program
|Proceedings of the National Academy of Sciences|2014|153
Suppression of replicative senescence by rapamycin in rodent embryonic cells
|Cell Cycle|2012|83
Prevention of Age-Related Macular Degeneration–Like Retinopathy by Rapamycin in Rats
|American Journal Of Pathology|2012|81
Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)
|Oncotarget|2015|65
Gerosuppression by pan-mTOR inhibitors
|Aging|2016|65